These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19617415)

  • 21. Transgenic mouse models of sickle cell disease.
    Beuzard Y
    Curr Opin Hematol; 1996 Mar; 3(2):150-5. PubMed ID: 9372066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice.
    Kaul DK; Liu XD; Choong S; Belcher JD; Vercellotti GM; Hebbel RP
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H293-301. PubMed ID: 15001449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease.
    Conran N; Saad ST; Costa FF; Ikuta T
    Ann Hematol; 2007 Apr; 86(4):255-61. PubMed ID: 17205286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function.
    Shi PA; Choi E; Chintagari NR; Nguyen J; Guo X; Yazdanbakhsh K; Mohandas N; Alayash AI; Manci EA; Belcher JD; Vercellotti GM
    Br J Haematol; 2016 Nov; 175(4):714-723. PubMed ID: 27507623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress.
    De Backer O; Elinck E; Blanckaert B; Leybaert L; Motterlini R; Lefebvre RA
    Gut; 2009 Mar; 58(3):347-56. PubMed ID: 19022916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
    Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
    Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.
    Gomperts E; Belcher JD; Otterbein LE; Coates TD; Wood J; Skolnick BE; Levy H; Vercellotti GM
    Am J Hematol; 2017 Jun; 92(6):569-582. PubMed ID: 28378932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice.
    Mahaseth H; Vercellotti GM; Welch TE; Bowlin PR; Sonbol KM; Hsia CJ; Li M; Bischof JC; Hebbel RP; Belcher JD
    J Lab Clin Med; 2005 Apr; 145(4):204-11. PubMed ID: 15962839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
    PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor.
    Roberts AW; Foote S; Alexander WS; Scott C; Robb L; Metcalf D
    Blood; 1997 Apr; 89(8):2736-44. PubMed ID: 9108391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease.
    Zhao Y; Schwartz EA; Palmer GM; Zennadi R
    FASEB J; 2016 Mar; 30(3):1171-86. PubMed ID: 26631480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of inhaled carbon monoxide during pulmonary inflammation in mice.
    Wilson MR; O'Dea KP; Dorr AD; Yamamoto H; Goddard ME; Takata M
    PLoS One; 2010 Jul; 5(7):e11565. PubMed ID: 20644637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice.
    Gbotosho OT; Kapetanaki MG; Ghosh S; Villanueva FS; Ofori-Acquah SF; Kato GJ
    Front Immunol; 2020; 11():1910. PubMed ID: 32973791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered hematopoiesis in murine sickle cell disease.
    Blouin MJ; De Paepe ME; Trudel M
    Blood; 1999 Aug; 94(4):1451-9. PubMed ID: 10438733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitations of a mouse model of sickle cell anemia.
    Ieremia J; Blau CA
    Blood Cells Mol Dis; 2002; 28(2):146-51. PubMed ID: 12064910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.
    Hanson MS; Xu H; Flewelen TC; Holzhauer SL; Retherford D; Jones DW; Frei AC; Pritchard KA; Hillery CA; Hogg N; Wandersee NJ
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H328-36. PubMed ID: 23125208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease.
    Jison ML; Munson PJ; Barb JJ; Suffredini AF; Talwar S; Logun C; Raghavachari N; Beigel JH; Shelhamer JH; Danner RL; Gladwin MT
    Blood; 2004 Jul; 104(1):270-80. PubMed ID: 15031206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
    PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of carbon monoxide inhalation during experimental endotoxemia in humans.
    Mayr FB; Spiel A; Leitner J; Marsik C; Germann P; Ullrich R; Wagner O; Jilma B
    Am J Respir Crit Care Med; 2005 Feb; 171(4):354-60. PubMed ID: 15557136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide.
    Neto JS; Nakao A; Kimizuka K; Romanosky AJ; Stolz DB; Uchiyama T; Nalesnik MA; Otterbein LE; Murase N
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F979-89. PubMed ID: 15292046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.